Beraprost is a synthetic prostacyclin analog used as a vasodilator and antiplatelet agent in the treatment of pulmonary hypertension and for avoiding reperfusion injury. Because pharmaceutical quality… Read more
























Beraprost is a synthetic prostacyclin analog used as a vasodilator and antiplatelet agent in the treatment of pulmonary hypertension and for avoiding reperfusion injury. Because pharmaceutical quality is paramount, laboratories utilize Beraprost reference standards, including pharmacopeial and non-pharmacopeial impurities, diastereomers, and methyl esters, to ensure analytical precision and regulatory compliance. These compounds are essential for accurate impurity profiling, method validation, and routine batch release testing. Furthermore, stable isotope labelled compounds are critical in mass spectrometry-based analytical testing, serving as internal standards to improve the accuracy of quantification in bioanalytical studies. By using these highly characterized reference materials, researchers and quality control professionals can effectively identify, isolate, and quantify degradation products and process-related contaminants, ensuring the safety and consistency of the final drug product throughout its lifecycle.